<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Several key reports from the American Heart Association meeting, held in Orlando (FL, USA) in November 2011, are presented related to anti-thrombotic therapy in <z:hpo ids='HP_0011009'>acute</z:hpo> coronary syndrome and the use of <z:chebi fb="0" ids="50659">dronedarone</z:chebi> in <z:hpo ids='HP_0004754'>permanent atrial fibrillation</z:hpo> is discussed in this brief (and selective) overview of this meeting </plain></SENT>
<SENT sid="1" pm="."><plain>A summary of the ATLAS-TIMI-51, TRACER and PALLAS trials is provided </plain></SENT>
</text></document>